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Encapsulation of yeast in liquid core gel membrane capsules 
has been shown to improve the inhibitor tolerance and even 
thermo-tolerance of yeast(1,2). Encapsulation is therefore a 
very promising bioprocessing methodology for second 
generation bioethanol production using lignocellulose hydro- 
 
lyzates. However, for industrial applications, capsules must be 
made robust enough to endure long periods and numerous cul-
tivations without breakage due to chemical degradation or 
mechanical attrition.  
In this study, liquid core Alginate-Chitosan-Alginate (ACA) 
 
capsules containing Saccharomyces cerevisiae were produced 
by the liquid-droplet-forming method and treated with 3-
aminopropyltrietoxysilane (APTES) to coat the increase the 
mechanical durability of the capsules. The integrity of these 
membranes is not compromized by a lack of Ca2+ ions.  
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CO NC LU S I O NS  
RESULTS 
INTRODUCTION 
Robustness test 
The yeast Saccharomyces 
cerevisiae CBS8066 was 
encapsulated by dripping a 
suspension of yeast with CaCl2 
and CMC into a Na-alginate 
solution. The resulting capsules 
were treated with  chitosan 
dissolved in acetate buffer. A 
second coating of alginate was 
added, after which the alginate - 
chitosan - alginate (ACA) capsules 
were treated with different 
concentrations of 3-aminopropyl-
trietoxysilane, hydrolyzed over-
night in water. This results in poly-
(3-aminopropylsiloxane) - alginate 
- chitosan - alginate capsules. 
 
The encapsulated yeast was propa-
gated aerobically 24 h in defined 
glucose medium, before being 
used in hydrolysate fermentations. 
Fermentation efficiency 
Encapsulation procedure 
Viability after 5 batch fermentations 
Permeability of the capsules 
The mechanical robustness of ACA capsules can be 
easily improved by treating the capsules with hAPTES. 
Capsules treated with 1.5% hAPTES showed excellent 
mechanical robustness and similar ethanol production 
profile as untreated ACA capsules in the fifth 
consecutive batch cultivation. The obtained poly(3-
aminopropylsiloxane) - alginate - chitosan - alginate 
capsules are likely to be appropriate for industrial 
application. 
Table I. Calculated volumetric mass transfer coefficient (K) 
of components into empty untreated or hAPTES treated ACA 
capsules. Calculated based on the average of two samples.   
a Calculated based on data points from 0-40 min  
ACA capsules had poor mechanical robustness, since 
25% of the capsules ruptured within 6 h when subjected 
to intense agitation. Capsules treated with a 1.5% 
hAPTES solution were more robust, and only 0-2% of 
these capsules broke in the shear test.  
K (cm3/min) 
hAPTES conc. 0% 0.75% 1.5% 3.0% 
Glucose 5.2 4.2 2.4 1.9 
Acetic acid 8.6 8.6 5.5 5.7 
HMF 7.0 6.0 3.9 3.2 
Furfural 6.1a 5.6a 4.0a 3.8a 
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During pretreatment and / or hydrolysis of ligno-
cellulosic raw materials, inhibitors are generated as 
degradation products from both the lignin and 
hemicellulose fractions. Encapsulation enables 
fermentation of such inhibitory hydrolyzates(1,3). The 
fermentation rate in the hAPTES-treated capsules was 
lower than in the ACA capsules in the first batches. 
However in the fifth repeated batch, the ethanol 
production was nearly the same as for untreated ACA 
capsules 
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The robustness was examined by mixing 100 capsules 
with 35 ml 0.9% NaCl in a baffled 200 ml SARA-
fermentor (custom made by Belach Bioteknik, 
Stockholm, Sweden). The contents were mixed 
vigorously at 600 rpm at room temperature.  
The cell content in the capsules decreased with 
increasing hAPTES concentration. This was clear both 
after the aerobic propagation culture and after the five 
repeated anaerobic hydrolyzate fermentations. 
However, because the size of the capsules decreased 
during hAPTES treatment, the concentration of cells 
inside the capsules was approximately equal, 13-14 g/l, 
up to 1.5% hAPTES. In the 3% hATPES treatment, 
cell viability was very low, likely due to a negative 
effect of the hAPTES or the low permeability of these 
capsules. 
Treatment with hAPTES caused a decrease in the 
permeability of the capsule membrane. The decrease 
was dependent on the hAPTES concentration.  
 
Capsules were immersed in solutions containg 50 mM 
of the indicated compounds, and the concentration was 
monitored. The volumetric overall mass transfer 
coefficient K was estimated from the decrease in the 
solute concentration in the liquid surrounding the 
capsules. 
